Pilot study: placental biomarker predictive capability (sFlt-1, PlGF and their ratio) of postpartum maternal outcome

@article{Hamza2019PilotSP,
  title={Pilot study: placental biomarker predictive capability (sFlt-1, PlGF and their ratio) of postpartum maternal outcome},
  author={Amr Hamza and Ch Gerlinger and Julia Caroline Radosa and Erich-Franz Solomayer and Joseph A Hagmann and Urban Sester and Rainer Maria Bohle and Russalina Stroeder and Zoltan Ferenc Takacs and Gabriele Meyberg-Solomayer and Ingolf Juhasz-Boess and Mariz Kasoha},
  journal={Archives of Gynecology and Obstetrics},
  year={2019},
  pages={1-10}
}
Prenatal measurement of placental biomarkers was able to improve screening and diagnosis of preeclampsia. Little is known about the clinical role of placental biomarkers in the postpartum period. This study is a prospective monocentric trial that included a total of 30 women with preeclamptic pregnancies. Serum placental biomarkers including soluble fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PlGF) were measured before and 2 h after delivery by Enzyme-Linked Immunosorbent… CONTINUE READING
BETA

References

Publications referenced by this paper.
SHOWING 1-10 OF 38 REFERENCES

Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.

  • Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
  • 2018
VIEW 3 EXCERPTS

Effects of postpartum uterine curettage in the recovery from preeclampsia/eclampsia. A randomized, controlled trial

G Mc Lean, O Reyes, R Velarde
  • Pregnancy Hypertens
  • 2017
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…